TipRanks

Neil Lerner Insider Profile

4 Followers
Neil Lerner, CAO at Compass Therapeutics, holds 400.00K shares in Compass Therapeutics (Ticker: CMPX), holds 25.87K shares in Psychemedics (Ticker: PMDI). Most recently, Neil Lerner Bought ― shares of Compass Therapeutics on Sep 25, 2026 for an estimated value of $2.85K.
tipranks
Neil Lerner

Neil Lerner
Compass Therapeutics (CMPX)
CAO

Ranked #5,615 out of 109,193 Corporate Insiders

Profitable Transactions

80%
4 out of 5 Profitable Transactions

Average Return

+72.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$508K
87.33%
12.67%
A breakdown of Neil Lerner's holdings

Insider Roles

Compass Therapeutics
(CMPX)
CAO
Psychemedics
(PMDI)
VP - Finance
Roles that Neil Lerner holds in companies

Most Profitable Insider Trade

Stock:
Compass Therapeutics
(CMPX)
Rating:Informative Buy
Date:Apr 08, 2025 - Apr 08, 2026
Return:+239.60%
The most profitable trade made by Neil Lerner

Neil Lerner's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Compass Therapeutics
Sep 25, 2026
CAO
Informative Buy
2.85K
$444.00K
Psychemedics
Nov 13, 2020
VP - Finance
Uninformative Buy
―
$64.41K
List of latest transactions for each holding click on a transaction to see Neil Lerner's performance on stock

Neil Lerner insider profile FAQ

What is the percentage of profitable transactions made by Neil Lerner?
The percentage of profitable transactions made by Neil Lerner is 80%.
    What is the average return per transaction made by Neil Lerner?
    The average return per transaction made by Neil Lerner is 72.30%.
      What stocks does Neil Lerner hold?
      Neil Lerner holds: CMPX, PMDI stocks.
        What was Neil Lerner’s latest transaction?
        Neil Lerner latest transaction was an Informative Buy of $2.85K.
          What was Neil Lerner's most profitable transaction?
          Neil Lerner’s most profitable transaction was an Informative Buy of CMPX stock on April 8, 2025. The return on the trade was 239.60%.
            What is Neil Lerner's role in Compass Therapeutics?
            Neil Lerner's role in Compass Therapeutics is CAO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.